已收盤 12-05 16:00:00 美东时间
+0.790
+1.98%
CERo Therapeutics Hldgs (NASDAQ:CERO) reported quarterly losses of $(9.10) per share which missed the analyst consensus estimate of $(2.94) by 210.05 percent. This is a 94.65 percent increase over losses of $(170.22) per
11-20 08:36
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Wells Fargo analyst Michael Sison maintains Celanese (NYSE:CE) with a Overweight and lowers the price target from $57 to $55.
11-10 22:30
(来源:链塑网) 全球化工巨头塞拉尼斯公布2025年第三季度业绩。公司实现净销售额24亿美元,调整后每股收益1.34美元。尽管面临市场需求挑战,公司展现出强劲...
11-10 18:37
U.S. stocks were lower, with the Nasdaq Composite falling more than 1% on Frida...
11-08 02:42
Celanese shares are trading higher after the company reported better-than-expec...
11-07 05:34
Celanese (NYSE:CE) is looking for Q4 Adj EPS of $0.85-$1.00 vs $1.01 analyst estimate..
11-07 05:14
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12